Novartis Re-starts Elidel TV Ad Featuring Cartoon Superhero
This article was originally published in The Pink Sheet Daily
The company says that total Rx market share increased by 1.4% in the month following January debut of the direct-to-consumer campaign. Novartis ended the ad April 23, but re-started it in September.
You may also be interested in...
Although noting that data suggesting a cancer risk from the topical eczema treatments is not definitive, the panel concludes that a black box warning is the best approach to discourage off-label use. A medication guide should also be mandated, the committee says.
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.